Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots

Area of Science:

• Genetics and Molecular Biology
• Neurology
• Medical Diagnostics

Background:

• Spinal muscular atrophy (SMA) is a genetic lower motor neuron disease characterized by muscle weakness and atrophy.
• Over 90% of SMA cases result from homozygous deletion of the survival motor neuron 1 (SMN1) gene.
• Current treatments offer improved outcomes, but delayed diagnosis due to invasive testing hinders timely access to care.

Purpose of the Study:

• To develop a completely non-invasive screening system for SMA detection.
• To utilize dried saliva spots (DSS) as a novel DNA source for identifying SMN1 deletion.
• To establish an efficient and accessible diagnostic method for SMA.

Main Methods:

• Development of a non-invasive screening system using dried saliva spots (DSS).
• Application of modified competitive oligonucleotide priming-polymerase chain reaction (mCOP-PCR) and melting peak analysis.
• Testing of 60 DSS samples, including 40 from SMA patients and 20 from controls.

Main Results:

• The developed system successfully distinguished between DSS samples with and without SMN1 deletion.
• The combination of mCOP-PCR and melting peak analysis demonstrated high accuracy in detecting SMN1 deletion from saliva.
• The system proved effective in differentiating SMA patients from control individuals using DSS.

Conclusions:

• The developed non-invasive screening system using DSS is a viable and practical tool for SMA detection.
• This novel approach offers a less invasive and potentially more accessible alternative to current diagnostic methods.
• The findings support the real-world applicability of DSS-based screening for early identification of SMA patients.